Description

Temomedak (temozolomide) capsules 180 mg. №5 vial

Ingredients:

Each capsule contains 180 mg of temozolomide.

Dosage:

The recommended dosage is determined by a healthcare provider based on individual factors. It is typically taken once daily for a specific number of days as part of a treatment cycle.

Indications:

Temomedak is indicated for the treatment of certain types of brain tumors, specifically glioblastoma multiforme. It is used in combination with radiation therapy for newly diagnosed patients and as maintenance therapy for recurrent tumors.

Contraindications:

Do not use Temomedak if you are allergic to temozolomide or any of the ingredients in the capsules. It is important to inform your healthcare provider about any medical conditions or medications you are taking before starting treatment.

Directions:

Take Temomedak exactly as prescribed by your doctor. Swallow the capsules whole with a full glass of water. Do not crush, chew, or open the capsules.

Scientific Evidence:

Studies have shown that temozolomide, the active ingredient in Temomedak, is effective in treating glioblastoma multiforme by inhibiting the growth of cancer cells. Research published in the New England Journal of Medicine demonstrated the efficacy of temozolomide in improving overall survival rates in patients with this aggressive form of brain cancer.

Additional Information:

It is important to follow all instructions provided by your healthcare provider while taking Temomedak. Regular monitoring and blood tests may be necessary during treatment to assess your response to the medication and manage any potential side effects. If you experience any severe or persistent side effects, contact your doctor immediately.

Discuss with your healthcare provider about the potential benefits and risks of Temomedak treatment. They can provide you with more detailed information about the medication and answer any questions you may have regarding its use and expected outcomes.